Aclarion (ACON) Return on Capital Employed (2022 - 2026)
Aclarion (ACON) reported Return on Capital Employed of 52.86% for Q1 2026, down 6737.0% on a YoY basis from 0.8% in Q1 2025, and up 5.57% quarter-over-quarter from 55.98% in Q4 2025.
Aclarion (ACON) Return on Capital Employed (2022 - 2026) Analysis & Trends
Aclarion has reported Return on Capital Employed for 5 years, with the latest figure at 52.86% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 6737.0% year-over-year to 52.86%; the trailing twelve-month figure through Mar 2026 stood at 52.86% (down 6737.0% YoY), and the FY2025 full-year result was 99.88%, down 22862.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 52.86%, up from 55.98% in the prior quarter.
- The five-year high for Return on Capital Employed was 8424.12% in Q2 2023, with the low at 361.45% in Q1 2023.
- Historically, Return on Capital Employed has averaged 500.42% across 5 years, with a median of 54.42% in 2026.
- Annual changes were most pronounced in 2023 — Return on Capital Employed soared 863207 bps — and 2024, when it slumped 866371 bps.
- Aclarion's Return on Capital Employed stood at 197.27% in 2022, then jumped by 308 bps to 411.03% in 2023, then tumbled by 76 bps to 97.53% in 2024, then tumbled by 157 bps to 55.98% in 2025, then advanced by 6 bps to 52.86% in 2026.
- The last three Return on Capital Employed figures came in at 52.86% (Q1 2026), 55.98% (Q4 2025), and 0.85% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 13.00% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 2.09% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 10.67% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -163.65% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -4.23% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 21.81% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 4.73% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 4.60% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 2.23% |
| 10 | Aclarion | 6.68 Mn | -12.07 Mn | 3,750.00 | -52.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.86% |
| Dec 31, 2025 | -55.98% |
| Sep 30, 2025 | 0.85% |
| Jun 30, 2025 | 4.30% |
| Mar 31, 2025 | 14.51% |
| Dec 31, 2024 | 97.53% |
| Sep 30, 2024 | -196.46% |
| Jun 30, 2024 | -239.59% |
| Mar 31, 2024 | -265.53% |
| Dec 31, 2023 | 411.03% |
| Sep 30, 2023 | 785.48% |
| Jun 30, 2023 | 8,424.12% |
| Mar 31, 2023 | -361.45% |
| Dec 31, 2022 | -197.27% |
| Sep 30, 2022 | -154.03% |
| Jun 30, 2022 | -207.95% |